Molecular Insights into Phytochemicals Mediated Epigenetic Regulation in Preclinical Models of Breast Cancer
Drug Design, Development and Therapy · 2025
DOI: 10.2147/dddt.s554844 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Drug Design, Development and Therapy, 2025. Verfasst von Pratibha Pandey und 10 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Research Impact and Outcome, Chitkara University, Rajpura, Punjab, India. Hauptthemen laut MEDLINE: Breast Neoplasms, Epigenesis, Genetic, Phytochemicals, Antineoplastic Agents, Phytogenic. Die Arbeit nennt 161 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
One of the most common malignant tumors in women worldwide is breast cancer, which affects even more than one-third of all female tumor patients. Patient outcomes and effective therapeutic strategies are frequently determined by molecular subtypes in breast cancer. However, the underlying epigenetic characteristics that could further divide breast cancer patients into groups and affect their outcomes could be the reason for the differences in therapeutic response. It is true that there have been recent findings about the role of epigenetic abnormalities in cancer, and that therapeutics targeting particular epigenetic pathways have been developed. Phytochemicals function as gene regulators in a variety of cancers and are crucial to the pathophysiology of many human cancers, including breast cancer. Preclinical studies have revealed that phytochemicals exhibit promising therapeutic efficacy against breast carcinoma by modulating several epigenetic alterations including DNA methylation, histone modifications, non-coding RNA and estrogen associated epigenetic changes. Nevertheless, despite promising in vitro and in vivo results, the clinical application of phytochemicals targeting epigenetic markers in breast cancer is limited. Further research is required to confirm their effectiveness and safety in clinical settings. Thus, this study provides a thorough summary of how epigenetic changes contribute to the development of breast cancer. This article also explores the potential benefits of phytochemicals, such as flavonoids, terpenoids, alkaloids, isothiocyanates, and quinones, in modulating these epigenetic markers in preclinical models of breast cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Research Impact and Outcome, Chitkara University, Rajpura, Punjab, India.
- Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Khalid University, Abha, Saudi Arabia.
- Department of Biology, College of Science, University of Hail, Hail, Saudi Arabia.
- Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, University of Hail, Hail, Saudi Arabia.
- Research and Innovation Cell, Bahra University, Waknaghat, HP, India.
- Department of Biology, Faculty of Mathematics and Natural Sciences, Universitas Sam Ratulangi, Manado, Indonesia.
ORCID-Profile: Mohd Saeed, Fahad Khan
Zitieren
APA
Pandey, P., Alkhathami, A. G., Saeed, M., Alshaghdali, K., Kumar, S., Tallei, T. E., Bae, H., Park, M. N., Kumar, G., Kim, B., & Khan, F. (2025). Molecular Insights into Phytochemicals Mediated Epigenetic Regulation in Preclinical Models of Breast Cancer. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s554844
Vancouver
Pandey P, Alkhathami AG, Saeed M, Alshaghdali K, Kumar S, Tallei TE, et al. Molecular Insights into Phytochemicals Mediated Epigenetic Regulation in Preclinical Models of Breast Cancer. Drug Design, Development and Therapy. 2025. doi:10.2147/dddt.s554844
BibTeX
@article{Pandey2025,
author = {Pandey, Pratibha and Alkhathami, Ali G and Saeed, Mohd and Alshaghdali, Khalid and Kumar, Sandeep and Tallei, Trina Ekawati and Bae, Hanul and Park, Moon Nyeo and Kumar, Gaurav and Kim, Bonglee and Khan, Fahad},
title = {Molecular Insights into Phytochemicals Mediated Epigenetic Regulation in Preclinical Models of Breast Cancer},
journal = {Drug Design, Development and Therapy},
year = {2025},
doi = {10.2147/dddt.s554844}
}
EUVIMED